Document:

EX-10.5

 Exhibit 10.5 

AMENDMENT 
 TO THE

 1979 RESTRICTED STOCK AND PERFORMANCE SHARE AWARD PLAN 

WHEREAS, on June 15, 2014, Medtronic, Inc. (“Medtronic”) entered into a Transaction Agreement with Covidien plc and the
other parties named therein (the “Transaction Agreement”) to acquire Covidien through the formation of a new holding company incorporated in Ireland that will be renamed Medtronic plc (the “Transaction”); and 

WHEREAS, Medtronic maintains the Medtronic, Inc. 1979 Restricted Stock and Performance Share Award Plan, as amended (the “1979 Stock
Plan”); and 
 WHEREAS, in connection with the Transaction, the 1979 Stock Plan is being assumed by Medtronic plc and certain
technical changes are required in connection with the Transaction and assumption. 
 NOW THEREFORE, the 1979 Stock Plan shall be and hereby
is amended in the following respects, effective as of the Effective Time (as defined in the Transaction Agreement): 
  

	 	1.	References to “Medtronic, Inc.” are hereby replaced with references to “Medtronic plc”. 

  

	 	2.	“Company” is hereby defined to mean Medtronic plc, an Irish public limited company, and its subsidiaries. 

  

	 	3.	“Common Stock” is hereby defined to mean ordinary shares, par value $0.0001, of the Company. 

  

	 	4.	“Subsidiary” is hereby defined as having the meaning set forth in section 155 of the Companies Act 1963 of the Republic of Ireland; provided that, to the extent required to avoid the imposition of additional
taxes under Section 409A of the Code, an entity shall not be treated as a Subsidiary unless it is also an entity in which the Company has a “controlling interest” (as defined in Treas. Reg. Section 1.409A-1(b)(5)(ii)(E)(1)),
either directly or through a chain of corporations or other entities in which each corporation or other entity has a “controlling interest” in another corporation or entity in the chain, as determined by the Committee. 

 

	 	5.	The following language shall replace the words “any Eligible Employee” in the first sentence of Section 7(b)(iii): “to the extent permitted by law, an Eligible Employee”. 

 

	 	6.	The following language is hereby added to the beginning of the first sentence of the second paragraph in Section 8(c): “To the extent permitted by applicable law,”. 

 

	 	7.	The following sentence is hereby added to the end of Section 11: “Notwithstanding the foregoing, in no event shall the subscription price payable per share of Common Stock covered by a Restricted Stock or
Performance Share Award be reduced to an amount that is lower than the nominal value of a share of Common Stock.” 

	 	8.	The following language is hereby added to the beginning of the first sentence of the second paragraph in Section 15: “To the extent permitted by applicable law,”. 

 

	 	9.	A new sub-section (f) in Section 16 is hereby added containing the following language: 

Irish Conditions for Issuance. Notwithstanding any other provision of this Plan, (a) the Company shall not be obliged to issue any shares
of Common Stock pursuant to an award unless at least the par (nominal) value of such newly issued share of Common Stock has been fully paid in advance in accordance with applicable law (which requirement may mean the holder of an award is obliged to
make such payment) and (b) the Company shall not obliged to issue or deliver any shares of Common Stock in satisfaction of awards until all legal and regulatory requirements associated with such issue or delivery have been complied with to the
satisfaction of the Committee. 
  

	 	10.	The following language is hereby added to the end of the definition of “Change in Control” set forth in Section 17(c): “For the avoidance of doubt, any one or more of the above events may be effected
pursuant to (A) a compromise or arrangement sanctioned by the court under section 201 of the Companies Act 1963 of the Republic of Ireland or (B) section 204 of the Companies Act 1963 of the Republic of Ireland.” 

  
 2EX-10.6

 Exhibit 10.6 

AMENDMENT 
 TO THE

 1979 NONQUALIFIED STOCK OPTION PLAN 

WHEREAS, on June 15, 2014, Medtronic, Inc. (“Medtronic”) entered into a Transaction Agreement with Covidien plc and the
other parties named therein (the “Transaction Agreement”) to acquire Covidien through the formation of a new holding company incorporated in Ireland that will be renamed Medtronic plc (the “Transaction”); and 

WHEREAS, Medtronic maintains the Medtronic, Inc. 1979 Nonqualified Stock Option Plan, as amended (the “1979 Option Plan”);
and 
 WHEREAS, in connection with the Transaction, the 1979 Option Plan is being assumed by Medtronic plc and certain technical changes are
required in connection with the Transaction and assumption. 
 NOW THEREFORE, the 1979 Option Plan shall be and hereby is amended in the
following respects, effective as of the Effective Time (as defined in the Transaction Agreement): 
  

	 	1.	References to “Medtronic, Inc.” are hereby replaced with references to “Medtronic plc”. 

  

	 	2.	“Company” is hereby defined to mean Medtronic plc, an Irish public limited company. 

  

	 	3.	“Common Stock” is hereby defined to mean ordinary shares, par value $0.0001, of the Company. 

  

	 	4.	“Subsidiary” is hereby defined as having the meaning set forth in section 155 of the Companies Act 1963 of the Republic of Ireland; provided that, to the extent required to avoid the imposition of additional
taxes under Section 409A of the Code, an entity shall not be treated as a Subsidiary unless it is also an entity in which the Company has a “controlling interest” (as defined in Treas. Reg. Section 1.409A-1(b)(5)(ii)(E)(1)),
either directly or through a chain of corporations or other entities in which each corporation or other entity has a “controlling interest” in another corporation or entity in the chain, as determined by the Committee. 

 

	 	5.	The following language is hereby added to the first sentence of the second paragraph of Section VII(A)(b), immediately preceeding clause (ii): “to the extent permitted by law,”. 

 

	 	6.	The following language is hereby added to the first sentence of the second paragraph of Section VII(A)(c): “To the extent permitted by law,”. 

 

	 	7.	The following language is hereby added to the end of Section VII(A)(g): “The foregoing provisions of this paragraph (g) shall be available to the Company to the extent permitted by applicable law.”

	 	8.	The following language is hereby added to the end of the last sentence of Section VII(B)(c): “, but in any event to the extent permitted by law.”. 

 

	 	9.	The following sentence is hereby added to the end of Section X: “Notwithstanding the foregoing provisions of this Section X, in no event shall the price per share of Common Stock covered by each option be
reduced to an amount that is lower than the nominal value of a share of Common Stock.” 

  

	 	10.	A new paragraph (e) is hereby added to Section XII containing the following language: 

Irish Conditions for Issuance. Notwithstanding any other provision of this Plan, (a) the Company shall not be obliged to issue any
shares of Common Stock pursuant to an award unless at least the par (nominal) value of such newly issued share of Common Stock has been fully paid in advance in accordance with applicable law (which requirement may mean the holder of an award is
obliged to make such payment) and (b) the Company shall not obliged to issue or deliver any shares of Common Stock in satisfaction of awards until all legal and regulatory requirements associated with such issue or delivery have been complied
with to the satisfaction of the Stock Option Committee. 

  
 2EX-10.7

 Exhibit 10.7 

AMENDMENT 
 TO THE

 1994 STOCK AWARD PLAN 

WHEREAS, on June 15, 2014, Medtronic, Inc. (“Medtronic”) entered into a Transaction Agreement with Covidien plc and the
other parties named therein (the “Transaction Agreement”) to acquire Covidien through the formation of a new holding company incorporated in Ireland that will be renamed Medtronic plc (the “Transaction”); and 

WHEREAS, Medtronic maintains the 1994 Stock Award Plan, as amended (the “1994 Plan”); and 

WHEREAS, in connection with the Transaction, the 1994 Plan is being assumed by Medtronic plc and certain technical changes are required in
connection with the Transaction and assumption. 
 NOW THEREFORE, the 1994 Plan shall be and hereby is amended in the following respects,
effective as of the Effective Time (as defined in the Transaction Agreement): 
  

	 	1.	References to “Medtronic, Inc.” are hereby replaced with references to “Medtronic plc”. 

  

	 	2.	“Affiliate” is hereby defined to mean a corporation or other entity controlled by, controlling, or under common control with, the Company. 

 

	 	3.	The following language is hereby added to the end of the definition of “Change in Control”: “For the avoidance of doubt, any one or more of the above events may be effected pursuant to (A) a
compromise or arrangement sanctioned by the court under section 201 of the Companies Act 1963 of the Republic of Ireland or (B) section 204 of the Companies Act 1963 of the Republic of Ireland.” 

 

	 	4.	“Company” is hereby defined to mean Medtronic plc, an Irish public limited company. 

  

	 	5.	“Stock” is hereby defined to mean ordinary shares, par value $0.0001, of the Company. 

  

	 	6.	“Subsidiary” is hereby defined as having the meaning set forth in section 155 of the Companies Act 1963 of the Republic of Ireland; provided that, to the extent required to avoid the imposition of additional
taxes under Section 409A of the Code, an entity shall not be treated as a Subsidiary unless it is also an entity in which the Company has a “controlling interest” (as defined in Treas. Reg. Section 1.409A-1(b)(5)(ii)(E)(1)),
either directly or through a chain of corporations or other entities in which each corporation or other entity has a “controlling interest” in another corporation or entity in the chain, as determined by the Committee. 

	 	7.	The following language is hereby added to the beginning of the seventh sentence in Section 7(a): “To the extent permitted by law,”. 

 

	 	8.	The following language is hereby added to the end of the first sentence of Section 14(f): “; provided, further, that in no event shall any adjustment operate so as to reduce the per Share exercise price of a
Stock Option or the subscription price per Share of an Award to an amount that is lower than the nominal value of a Share.” 

  

	 	9.	The following language is hereby added to the beginning of the first sentence in Section 14(j): “To the extent permitted by law,”. 

 

	 	10.	A new sub-section 14(n) is hereby added containing the following language: 

 Irish Conditions
for Issuance. Notwithstanding any other provision of this Plan, (a) the Company shall not be obliged to issue any Shares pursuant to an award unless at least the par (nominal) value of such newly issued Share has been fully paid in advance
in accordance with applicable law (which requirement may mean the holder of an award is obliged to make such payment) and (b) the Company shall not obliged to issue or deliver any Shares in satisfaction of awards until all legal and regulatory
requirements associated with such issue or delivery have been complied with to the satisfaction of the Committee. 

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]